TNGX
NASDAQStockTango Therapeutics, Inc.
$17.24+0.23 (+1.35%)
52-Week Range
$1.10
$17.15
Key Stats
Market Cap
1.9B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.81
Volume
1.9M
Avg Volume
4.5M
Performance
1M
+36.00%
3M
+88.05%
6M
+151.47%
YTD
+92.05%
1Y
+822.04%
3Y
+288.01%
5Y
+79.39%
Price Chart
ETF Exposure
TNGX is held by 56 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.00% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.00% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
PreviousPage 2 of 2
About TNGX ETF Exposure
Tango Therapeutics, Inc. (TNGX) is held by 56 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.9B, TNGX is a widely held institutional stock. The stock currently trades at $17.24. Investors can gain exposure to TNGX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TNGX, sorted by portfolio weight.